Does As­traZeneca CEO Pas­cal So­ri­ot re­al­ly want to merge with Gilead? A Bloomberg sto­ry sug­gests he was in­ter­est­ed — but it's hard to see why

Pas­cal So­ri­ot has ev­i­dent­ly been think­ing big.

Com­plete­ly out of left field, Bloomberg to­day post­ed a sto­ry ear­ly Sun­day say­ing that As­traZeneca ex­ecs have ap­proached Gilead to see if the big biotech would be in­ter­est­ed in join­ing up in a his­toric bio­phar­ma merg­er. No num­bers have been men­tioned yet, and no de­ci­sions have been made. Right now, ac­cord­ing to the busi­ness news ser­vice, it’s time to check every­one’s tem­per­a­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER